Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 4.25 ACUITE B | Downgraded | Issuer not co-operating* -
Bank Loan Ratings 3.25 - ACUITE A4 | Reaffirmed | Issuer not co-operating*
Total Outstanding 7.50 - -
Total Withdrawn 0.00 - -
* The issuer did not co-operate; based on best available information.
 
Rating Rationale

­­­Acuité has downgraded the long-term rating to 'ACUITE B’ (read as ACUITE B) from ‘ACUITE B+’ (read as ACUITE B plus) and reaffirmed the short term rating of ‘ACUITE A4’ (read as ACUITE A four) on the Rs. 7.50 crore bank facilities of ­Danash Mand Organic Private Limited (DMOPL) on account of information risk. The rating continues to be flagged as "Issuer Not-Cooperating" and is based on the best available information.


About the Company

­The Mumbai-based Danash Mand Organic Private Limited (DMOPL), incorporated in 1999, is engaged in the manufacturing of Pharma ingredients (API) at Roha (Maharashtra). The company manufactures Riboflavin-5-Phosphate Sodium, Metformin, Camphorquinone and Permethrin (Under process) to name a few. The company is led by Mrs Gurvinder Kaur (Managing Director) and Mr. Nagnath Govind Rao (Whole Time Director) with experience of two decades in the pharmaceuticals industry.

 
Unsupported Rating
­Not Applicable
 
Non-cooperation by the issuer/borrower:

­Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.

 
Limitation regarding information availability
Rating Sensitivity
­"No information provided by the issuer / available for Acuite to comment upon."
 
Liquidity Position
­"No information provided by the issuer / available for Acuite to comment upon."
 
Outlook
­Not Applicable
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 24 (Actual) FY 23 (Actual)
Operating Income Rs. Cr. 26.49 25.40
PAT Rs. Cr. 2.42 2.26
PAT Margin (%) 9.14 8.89
Total Debt/Tangible Net Worth Times 0.00 0.00
PBDIT/Interest Times 68.02 0.00
Status of non-cooperation with previous CRA
­Not Applicable
 
Any other information
­None
 
Applicable Criteria
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm
• Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
18 Apr 2024 Proposed Letter of Credit Short Term 3.25 ACUITE A4 (Reaffirmed & Issuer not co-operating*)
Proposed Cash Credit Long Term 4.25 ACUITE B+ (Reaffirmed & Issuer not co-operating*)
23 Jan 2023 Proposed Letter of Credit Short Term 3.25 ACUITE A4 (Reaffirmed & Issuer not co-operating*)
Proposed Cash Credit Long Term 4.25 ACUITE B+ (Reaffirmed & Issuer not co-operating*)
* The issuer did not co-operate; based on best available information.
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Not Applicable Not avl. / Not appl. Proposed Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 4.25 Simple ACUITE B | Downgraded | Issuer not co-operating* ( from ACUITE B+ )
Not Applicable Not avl. / Not appl. Proposed Letter of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 3.25 Simple ACUITE A4 | Reaffirmed | Issuer not co-operating*
* The issuer did not co-operate; based on best available information.

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in